Avidity Biosciences
67 hedge funds and large institutions have $755M invested in Avidity Biosciences in 2020 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
20% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 15
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
67
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$25.4M | |
| 2 | +$20.5M | |
| 3 | +$19.6M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$11M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.14M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$7.72M | |
| 3 | -$7.11M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$6.64M |
| 5 |
Millennium Management
New York
|
-$6.39M |